medigraphic.com
SPANISH

Archivos en Medicina Familiar

Órgano de Difusión de la Asociación Académica Panamericana de Medicina Familiar A.C.
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2024, Number 1

<< Back Next >>

Arch Med Fam 2024; 26 (1)

Post-COVID 19 Sequelae and their Impact on the Functional Status of Patients: Experience in a Family Medicine Unit in the State of Mexico

Ortiz VCM, Avilés SME
Full text How to cite this article

Language: Spanish
References: 18
Page: 29-34
PDF size: 189.68 Kb.


Key words:

COVID-19, Functional Status, Family Practice.

ABSTRACT

Objective: To describe the functional sequelae in patients who presented some type of post-COVID-19 sequelae. Methods: Cross-sectional, analytical and descriptive study. It was carried out in the Family Medicine Unit No. 220 of the Mexican Social Security Institute in the city of Toluca, State of Mexico. Non-probabilistic sampling, a sample of 117 patients was obtained; It was carried out between the months of June to December 2021. The Post-COVID- 19 Functional Status Scale (PCFS) was applied. Study approved by the Ethics and Research Committee. The data obtained were analyzed using the SPSS 26 statistical package. Results: Most representative age group: 30-40 years old (35.9%), women (67.5%). Married (59.8%). Secondary education (38.5%), high school (36.8%). Employees (76.1%). They reported hospitalization prevalence(33.3%). According to the degree of dysfunction: moderate 35%, mild 28.2%, minimal 18.8% and severe 8.5%. Main sequelae: fatigue (42.7%), neurocognitive alterations (29.1%). The result of χ˛ was 0.062, wich stablishes no statistical significance of association between the two main variables. Conclusions: The initial severity of COVID-19 does not always predict sequelae that lead the patient to modify their functional status. Family physicians should consider individual factors, educate patients about the variability of sequelae, adopt a multidisciplinary approach, and continuous follow-up.


REFERENCES

  1. Rubin R. As their numbers grow, COVID-19 “long haulers”stump experts. JAMA. 2020; 21(2): 123-211.

  2. Honigsbaum M, Krishnan L. Taking pandemic sequelaeseriously: from the Russian influenza to COVID-19long-haulers. Lancet. 2020; 396(33): 12-15.

  3. CDC. Evaluating and Caring for Patients with Post-COVIDConditions: Interim Guidance. [Online].; 2021[cited 2021 5. Available from: https://www.cdc.gov/coronavirus/2019-ncov/hcp/clinical-care/post-covid-index.html.

  4. National Institutes of Health. NIH intramural study onmyalgic encephalomyelitis/chronic fatigue syndrome.NIH. 2021; 2(3): 64-63.

  5. Anesi G, Jablonski J, Harhay M. Characteristics, Outcomes,and Trends of Patients With COVID-19-RelatedCritical Illness at a Learning Health System in the UnitedStates. Ann Intern Med. 2021; 174(5): 8-9.

  6. Salman D, Vishnubala D, Le Feuvre P. Returning to physicalactivity after covid-19. BMJ. 2021; 1(3): 38-42.

  7. Spruit M, Holland A, Singh S. COVID-19: Interim Guidanceon Rehabilitation in the Hospital and Post-HospitalPhase from a European Respiratory Society andAmerican Thoracic Society-coordinated InternationalTask Force. Eur Respir J. 2020; 2(1): 65-69.

  8. Barman M, Rahman T, Bora K, Borgohain C. COVID-19pandemic and its recovery time of patients in India:A pilot study. Diabetes Metab Syndr. 2021; 14(5): 102-111.

  9. Tenforde M, Billig RE, Lindsell C, Shapiro N. Characteristicsof Adult Outpatients and Inpatients with COVID-19 - 11 Academic Medical Centers, United States,March-May 2020. MMWR Morb Mortal Wkly Rep. 2021;69(26): 77-83.

  10. Frederikus A, Klok G, J.A.M B. The Post-COVID-19 FunctionalStatus scale: a tool to measure functional statusover time after COVID-19. European Respiratory Journal.2020; 1(2): 234-324.

  11. Havervall S, Rosell A, Phillipson M, al. e. Symptomsand functional impairment assessed 8 months aftermild COVID-19 among healthcare workers. JAMA. 2021;2(4): 54-61.

  12. Townsend L, Dowds J, O’Brien K, Sheill G, Dyer A, O’KellyB, et al. Persistent Poor Health after COVID-19 Is NotAssociated with Respiratory Complications or InitialDisease Severity. Ann Am Thorac Soc. 2021; 1(12): 997-1003.

  13. Nehme M, Braillard O, Chappuis F. Prevalence ofSymptoms More Than Seven Months After Diagnosis ofSymptomatic COVID-19 in an Outpatient Setting. AnnIntern Med. 2021; 2(3): 234-244.

  14. Del R, Malani P. COVID-19-New Insights on a RapidlyChanging Epidemic. JAMA. 2020; 323(14):64-71.

  15. Lavery A, Preston L, Ko J, Chevinsky J. Characteristics ofHospitalized COVID-19 Patients Discharged and ExperiencingSame-Hospital Readmission - United States,March-August 2020. MMWR Morb Mortal Wkly Rep.2020; 69(45+):50-62.

  16. Donnelly J, Wang X, Iwashyna T. Readmission and DeathAfter Initial Hospital Discharge Among Patients WithCOVID-19 in a Large Multihospital System. JAMA. 2021;325(3):1008-1025.

  17. Bowles K, McDonald M, Barrón Y. Post-covid syndromein individuals admitted to hospital with covid-19:retrospective cohort study. Ann Intern Med. 2021;174(3):98-99.

  18. Carfě A, Gemelli. Against COVID-19 Post-Acute CareStudy Group. Persistent symptoms in patients afteracute COVID-19. JAMA. 2020; 2(324): 603-605.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Arch Med Fam. 2024;26